A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases

BACKGROUND: The purpose was to compare the efficacy and safety of hepatic arterial infusion (HAI) of oxaliplatin plus raltitrexed (TOMOX) to those of oxaliplatin plus 5-fluorouracil (FOLFOX) for unresectable colorectal cancer liver metastases (CRCLM). METHODS: Patients with unresectable CRCLM were r...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ai-Wei, Guo, Jian-Hai, Gao, Song, Kou, Fu-Xin, Liu, Shao-Xing, Liu, Peng, Chen, Hui, Wang, Xiao-Dong, Xu, Hai-Feng, Cao, Guang, Zhu, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532863/
https://www.ncbi.nlm.nih.gov/pubmed/36212504
http://dx.doi.org/10.3389/fonc.2022.913017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532863/
https://www.ncbi.nlm.nih.gov/pubmed/36212504
http://dx.doi.org/10.3389/fonc.2022.913017

Ejemplares similares